Critical Review: Pheton (NASDAQ:PTHL) & OptimizeRx (NASDAQ:OPRX)

OptimizeRx (NASDAQ:OPRX) and Pheton (NASDAQ:PTHL) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.

Earnings & Valuation

This table compares OptimizeRx and Pheton”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OptimizeRx	$109.43 million	1.37	$5.13 million	$0.23	34.57
Pheton	$305,215.00	6.83	-$660,000.00	N/A	N/A

OptimizeRx has higher revenue and earnings than Pheton.

Volatility & Risk

OptimizeRx has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Pheton has a beta of 5.4, meaning that its stock price is 440% more volatile than the S&P 500.

Institutional and Insider Ownership

76.5% of OptimizeRx shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for OptimizeRx and Pheton, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OptimizeRx	1	2	6	0	2.56
Pheton	1	0	0	0	1.00

OptimizeRx currently has a consensus price target of $11.43, suggesting a potential upside of 43.76%. Given OptimizeRx’s stronger consensus rating and higher possible upside, research analysts plainly believe OptimizeRx is more favorable than Pheton.

Profitability

This table compares OptimizeRx and Pheton’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OptimizeRx	4.66%	9.44%	7.11%
Pheton	N/A	N/A	N/A

Summary

OptimizeRx beats Pheton on 10 of the 12 factors compared between the two stocks.

About OptimizeRx

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Pheton

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded in 1998 and is headquartered in Beijing, China.